N-3 polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 16, Issue 10, 2010, Pages 1696-1707

  Uchiyama, Kan ^a   Nakamura, Makoto ^a   Odahara, Shunichi ^a   Koido, Shigeo ^a   Katahira, Kiyohiko ^b   Shiraishi, Hiromi ^c   Ohkusa, Toshifumi ^a   Fujise, Kiyotaka ^a   Tajiri, Hisao ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOYO UNIVERSITY   (Japan)

^c UNIVERSITY OF HUMAN ARTS AND SCIENCES   (Japan)

Author keywords

Diet therapy; Inflammatory bowel disease; N 3 polyunsaturated fatty acid; N 3 n 6 ratio; Rate of remission maintenance

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; INFLIXIMAB; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TACROLIMUS;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIET THERAPY; DISEASE ACTIVITY; ERYTHROCYTE MEMBRANE; FEMALE; FOLLOW UP; FOOD INTAKE; HUMAN; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; REMISSION; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; DIET; ERYTHROCYTE MEMBRANE; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVENTION STUDIES; MALE; PROGNOSIS;

EID: 77955917752     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21251     Document Type: Article

References (33)

1. Tanaka C, Kato R,. NEW pharmacology, 2nd ed. Tokyo, PA: Nankodo; 1994.
2. Okuyama H,. Cancers as inflammatory disease caused by excessive intake of linoleic acid. Environ Mutagen Res. 2003; 25: 147-157.
3. van-Hees PAM, Bakker JH, van Tongeren JHM,. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine. Gut. 1980; 21: 632-635.
4. The IBD in EPIC Study Investigators. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested cases-control study within a European prospective cohort study. Gut. 2009; 58: 1606-1611
5. Okuyama H, Kobayashi T, Watanabe S,. Dietary fatty acids. The n-6/n-3 balance and chronic elderly disease. Prog Lipid Res. 1997; 35: 409-457.
6. Saku N, Kobayashi J, Kitamura S,. Eicosapentaenoic acid modulates arachidonic acid metabolism in rat alveolar macrophages activated by silica. Prostaglandins Leukot Essent Fatty Acids. 1999; 61: 51-54.
7. Igarashi O, Sugano M, Ikeda I, et al. A modern viewpoint of the fatty acid nutrition. Japanese Society of Nutrition and Food Science. Tokyo, PA: Koseikan; 1998.
8. Truelove SC, Witts LJ,. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J. 1955; 2: 1041-1048.
9. Schroeder KW, Tremaine WJ, Ilstrup DM, et al. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987; 317: 1625-1629.
10. Diet intake standards in Japanese established by the Ministry of Health, Labour and Welfare [2005 version]. Tokyo, PA: Daiichi Shuppan; 2005.
11. Dodge JT, Michelle C, Hanahan DJ,. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys. 1963; 100: 119-130.
12. Ohta A, Mayo MC, Kramer N, et al. Rapid analysis of fatty acids in plasma lipids. Lipids. 1990; 25: 742-747.
13. Matsueda K, Shoda R, Takazoe M, et al. Therapeutic efficacy of cyclic home elemental enteral alimentation in Crohn's disease: Japanese cooperative Crohn's disease study. J Gastroenterol. 1995; 30 (suppl 8): 91-94.
14. Axelsson C, Jarnum S,. Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease. Scand J Gastroenterol. 1977; 12: 89-95 (Pubitemid 8031770)
15. Takahashi H, Ando T, Watanabe O, et al. Usefulness of an elemental diet in Crohn's disease. Inflammopharmacology. 2007; 15: 15-17.
16. Zori G, Care M, Parazza M, et al. A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease. Aliment Pharmacol Ther. 1997; 11: 735-740.
17. Takagi S, Utsunomiya S, Kuriyama S, et al. Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: a randomized-controlled trial. Aliment Pharmacol Ther. 2006; 24: 1333-1340.
18. Sharon P, Stenson WF,. Enhanced synthesis of leucotriene B by colonic mucosa in inflammatory bowel disease. Gastroenterology. 1984; 86: 453-460.
19. Shimizu T, Fujii T, Suzuki R, et al. Effects of highly purified eicosapentaenoic acid on erythrocyte fatty acid composition and leukocyte and colonic mucosa leukotriene B4 production in children with ulcerative colitis. J Pediatr Gastroenterol Nutr. 2003; 37: 581-585.
20. Almallah YZ, El-Tahir A, Heys SD, et al. Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest. 2000; 30: 58-65.
21. Almallah YZ, Ewen SW, El-Tahir A, et al. Distal procto-colitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ. J Clin Immunol. 2000; 20: 68-76.
22. Lands WE, Libelt B, Morris A, et al. Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta. 1992; 1180: 147-162.
23. Camuesco D, Galvez J, Nieto A, et al. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr. 2005; 135: 687-694.
24. Shoda R, Matsueda K, Yamato S, et al. Therapeutic efficacy of N-3 polyunsaturated fatty acid in experimental Crohn's disease. J Gastroenterol. 1995; 30 (suppl 8): 98-101.
25. Needlemann P, Minkes M, Raz A,. Thromboxanes: selective biosynthesis and distinct biological properties. Science. 1976; 193: 163-165.
26. Bang HO, Dyerberg J, Hjorne N,. The composition of food consumed by Greenland Eskimos. Acta Med Scand. 1976; 200: 69-73.
27. Hamazaki T,. EPA/DHA as essential nutrients. Influence of fish oil on the physical and mental states. Tokyo, PA: Medical Tribune; 2002.
28. Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA. 2001; 285: 304-312.
29. Woodcock BE, Smith E, Lambert WH, et al. Beneficial effect of fish oil on blood viscosity in peripheral vascular disease. Br Med J. 1984; 288: 592-594.
30. Feagan BG, Sandborn WJ, Mittmann U, et al. Omaga-3 free fatty acids for maintenance of remission in Crohn disease: the EPIC randomized control trials. JAMA. 2008; 299: 1690-1697.
31. Glaz JFC, Soffers AEMF, Karan MB,. Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr. 1989; 49: 269-276.
32. Ma J, Folsom AR, Shahar E, et al. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. Am J Clin Nutr. 1995; 62: 564-571.
33. Subbaiah PV, Kaufman D, Bagdade JD,. Incorporation of dietary n-3 fatty acid into molecular species of phosphatidyl choline and cholesteryl ester in normal human plasma. Am J Clin Nutr. 1993; 58: 360-368.